Panacea Acquisition Corp. Announces the Separate Trading of its Shares of Class A Common Stock & Redeemable Warrants Commenci...
20 Agosto 2020 - 3:50PM
Business Wire
Panacea Acquisition Corp. (NYSE: PANA.U) (the “Company”) today
announced that, commencing August 21, 2020, holders of the units
sold in the Company’s initial public offering of 14,375,000 units
completed on July 6, 2020, may elect to separately trade the shares
of Class A common stock and redeemable warrants included in the
units. Those units not separated will continue to trade on the New
York Stock Exchange (the “NYSE”) under the symbol “PANA.U,” and the
shares of Class A common stock and redeemable warrants that are
separated will trade on the NYSE under the symbols “PANA” and “PANA
WS,” respectively. No fractional warrants will be issued upon
separation of the units and only whole warrants will trade. Holders
of units will need to have their brokers contact Continental Stock
Transfer & Trust Company, the Company’s transfer agent, in
order to separate the units into shares of Class A common stock and
redeemable warrants.
The units were initially offered by the Company in an
underwritten offering. Cowen acted as sole book-running manager of
the offering. A registration statement relating to the units and
the underlying securities was declared effective by the Securities
and Exchange Commission (the “SEC”) on June 30, 2020.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy the securities of the Company, nor
shall there be any sale of these securities in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction.
The offering was made only by means of a prospectus, copies of
which may be obtained for free from the SEC website at www.sec.gov
or by contacting Cowen, LLC, c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood, NY, 11717, Attn: Prospectus
Department, or by telephone at 631-274-2806, or by fax at
631-254-7140.
About Panacea Acquisition Corp.
Panacea Acquisition Corp. is a special purpose acquisition
company formed by an affiliate of EcoR1 Capital, LLC. While the
Company may pursue an initial business combination target in any
industry or geographic location, it intends to focus its search for
a target business operating in the biotechnology sector.
Forward Looking Statements
This press release may include “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. All statements other than statements of historical fact
included in this press release are forward-looking statements. When
used in this press release, words such as “anticipate,” “believe,”
“estimate,” “expect,” “intend” and similar expressions, as they
relate to us or our management team, identify forward-looking
statements. Such forward-looking statements are based on the
beliefs of management, as well as assumptions made by, and
information currently available to, the Company’s management.
Actual results could differ materially from those contemplated by
the forward-looking statements as a result of certain factors
detailed in the Company’s filings with the SEC. All subsequent
written or oral forward-looking statements attributable to us or
persons acting on our behalf are qualified in their entirety by
this paragraph. Forward-looking statements are subject to numerous
conditions, many of which are beyond the control of the Company,
including those set forth in the Risk Factors section of the
Company’s registration statement and prospectus relating to the
Company’s initial public offering filed with the SEC. The Company
undertakes no obligation to update these statements for revisions
or changes after the date of this release, except as required by
law.
Source: Panacea Acquisition Corp.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200820005801/en/
Investor Contact: Panacea Acquisition Corp. Oleg Nodelman
Please email: panacea@ecor1cap.com
Panacea Acquisition (NYSE:PANA.U)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Panacea Acquisition (NYSE:PANA.U)
Gráfica de Acción Histórica
De May 2023 a May 2024